annual SGA:
$484.98M+$18.13M(+3.88%)Summary
- As of today (May 24, 2025), GDRX annual SGA is $484.98 million, with the most recent change of +$18.13 million (+3.88%) on December 31, 2024.
- During the last 3 years, GDRX annual SGA has fallen by -$39.93 million (-7.61%).
- GDRX annual SGA is now -32.32% below its all-time high of $716.59 million, reached on December 31, 2020.
Performance
GDRX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$114.17M-$3.20M(-2.73%)Summary
- As of today (May 24, 2025), GDRX quarterly SGA is $114.17 million, with the most recent change of -$3.20 million (-2.73%) on March 31, 2025.
- Over the past year, GDRX quarterly SGA has dropped by -$16.90 million (-12.89%).
- GDRX quarterly SGA is now -72.53% below its all-time high of $415.69 million, reached on December 31, 2020.
Performance
GDRX quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
-$5.77B+$28.45M(+0.49%)Summary
- As of today (May 24, 2025), GDRX TTM SGA is -$5.77 billion, with the most recent change of +$28.45 million (+0.49%) on March 31, 2025.
- Over the past year, GDRX TTM SGA has dropped by -$6.26 billion (-1278.19%).
- GDRX TTM SGA is now -426.10% below its all-time high of -$1.10 billion.
Performance
GDRX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
GDRX Selling, general & administrative expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +3.9% | -12.9% | -1278.2% |
3 y3 years | -7.6% | -8.6% | -1196.4% |
5 y5 years | +153.0% | +65.3% | -3360.9% |
GDRX Selling, general & administrative expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -7.6% | +3.9% | -15.9% | +6.1% | -3.9% | +0.8% |
5 y | 5-year | -32.3% | +153.0% | -72.5% | +96.0% | -169.8% | +0.8% |
alltime | all time | -32.3% | +330.9% | -72.5% | +132.8% | -426.1% | +0.8% |
GDRX Selling, general & administrative expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $114.17M(-2.7%) | $468.08M(-3.5%) |
Dec 2024 | $484.98M(+3.9%) | $117.38M(+1.6%) | $484.98M(-1.4%) |
Sep 2024 | - | $115.49M(-4.6%) | $491.72M(-2.3%) |
Jun 2024 | - | $121.04M(-7.7%) | $503.17M(+2.7%) |
Mar 2024 | - | $131.07M(+5.6%) | $489.77M(+4.9%) |
Dec 2023 | $466.84M(-7.1%) | $124.12M(-2.2%) | $466.84M(+2.5%) |
Sep 2023 | - | $126.93M(+17.9%) | $455.43M(-1.9%) |
Jun 2023 | - | $107.65M(-0.5%) | $464.26M(-4.4%) |
Mar 2023 | - | $108.14M(-4.1%) | $485.69M(-3.3%) |
Dec 2022 | $502.42M | $112.71M(-17.0%) | $502.42M(-5.5%) |
Sep 2022 | - | $135.76M(+5.2%) | $531.58M(+0.8%) |
Jun 2022 | - | $129.08M(+3.4%) | $527.41M(+0.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | $124.87M(-12.0%) | $526.30M(+0.3%) |
Dec 2021 | $524.90M(-26.7%) | $141.87M(+7.8%) | $524.90M(-34.3%) |
Sep 2021 | - | $131.60M(+2.8%) | $798.73M(-5.0%) |
Jun 2021 | - | $127.96M(+3.6%) | $840.73M(+9.0%) |
Mar 2021 | - | $123.48M(-70.3%) | $771.02M(+7.6%) |
Dec 2020 | $716.59M(+273.9%) | $415.69M(+139.5%) | $716.59M(+99.2%) |
Sep 2020 | - | $173.59M(+198.0%) | $359.75M(+52.9%) |
Jun 2020 | - | $58.25M(-15.6%) | $235.21M(+32.9%) |
Mar 2020 | - | $69.05M(+17.3%) | $176.96M(+64.0%) |
Dec 2019 | $191.66M(+70.3%) | $58.85M(+20.0%) | $107.91M(+120.0%) |
Sep 2019 | - | $49.05M | $49.05M |
Dec 2018 | $112.54M | - | - |
FAQ
- What is GoodRx Holdings annual SGA?
- What is the all time high annual SGA for GoodRx Holdings?
- What is GoodRx Holdings annual SGA year-on-year change?
- What is GoodRx Holdings quarterly SGA?
- What is the all time high quarterly SGA for GoodRx Holdings?
- What is GoodRx Holdings quarterly SGA year-on-year change?
- What is GoodRx Holdings TTM SGA?
- What is the all time high TTM SGA for GoodRx Holdings?
- What is GoodRx Holdings TTM SGA year-on-year change?
What is GoodRx Holdings annual SGA?
The current annual SGA of GDRX is $484.98M
What is the all time high annual SGA for GoodRx Holdings?
GoodRx Holdings all-time high annual SGA is $716.59M
What is GoodRx Holdings annual SGA year-on-year change?
Over the past year, GDRX annual SGA has changed by +$18.13M (+3.88%)
What is GoodRx Holdings quarterly SGA?
The current quarterly SGA of GDRX is $114.17M
What is the all time high quarterly SGA for GoodRx Holdings?
GoodRx Holdings all-time high quarterly SGA is $415.69M
What is GoodRx Holdings quarterly SGA year-on-year change?
Over the past year, GDRX quarterly SGA has changed by -$16.90M (-12.89%)
What is GoodRx Holdings TTM SGA?
The current TTM SGA of GDRX is -$5.77B
What is the all time high TTM SGA for GoodRx Holdings?
GoodRx Holdings all-time high TTM SGA is -$1.10B
What is GoodRx Holdings TTM SGA year-on-year change?
Over the past year, GDRX TTM SGA has changed by -$6.26B (-1278.19%)